Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032
Description
Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032
The global hereditary testing market size is expected to reach USD 13.03 billion by 2032, according to a new study by Polaris Market Research. The report “Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into the current market dynamics and provides analysis on future market growth.
The hereditary testing market has experienced significant growth due to various factors. The increasing prevalence of hereditary disorders, rising awareness about the importance of early disease detection, and advancements in genetic testing technologies have contributed to the expansion of this market. Hereditary testing is crucial in identifying genetic mutations and abnormalities, enabling early intervention, personalized treatments, and informed decision-making for patients and their families.
Moreover, there has been a notable focus on women's healthcare and reproductive genetic health in the hereditary testing market. Companies are developing and offering specialized tests for women's health, such as carrier screening and prenatal testing, to assess the risk of hereditary conditions during pregnancy and enable informed choices.
However, the COVID-19 pandemic has presented challenges to the hereditary testing market. Disruptions in healthcare services, including limitations on in-person consultations and laboratory operations, have impacted the market's growth. Nevertheless, the market has shown resilience with adopting telemedicine and recognizing the importance of prenatal testing in maintaining the demand for hereditary testing services. As the understanding of genetics advances and technology continues to evolve, the hereditary testing market is expected to expand further in the coming years.
Hereditary Testing Market Report Highlights
The hereditary non-cancer testing segment dominated the market in 2022 and is projected to grow significantly. Major players are strategically targeting breast cancer genetic testing for revenue generation.
The molecular testing segment emerged as the market leader in 2022 and is expected to maintain strong growth due to increased adoption and strategic initiatives by market players.
Europe is projected to hold the largest revenue market share in 2022 and maintain dominance due to major genetic testing companies, widespread use of advanced therapies, and government regulations promoting hereditary testing.
The global key market players AL-KO KOBER GROUP, Andreas Stihl AG & Company KG, Ariens Company, Briggs & Stratton, CHEVRON (China) Trading Co., Ltd., Deere & Company, Emak S.p.A., Excel Industries, Inc., HONDA, Husqvarna, Makita Corp, MTD Holdings Inc., Robert Bosch, Schiller Ground Care, Stanley Black & Decker, STIHL Group, Techtronic Industries, The Toro Company (US), and Yamabiko Corp.
Polaris Market Research has segmented the Hereditary Testing market report based on disease type, technology, and region:
Hereditary Testing, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)
Hereditary Cancer Testing
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Prostate Cancer
Stomach/Gastric Cancer
Melanoma
Sarcoma
Uterine Cancer
Pancreatic Cancer
Others
Hereditary Non-Cancer Testing
Genetic Tests
Cardiac Diseases
Rare Diseases
Other Diseases
Newborn Genetic Screening
Preimplantation Genetic Diagnosis & Screening
Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
Hereditary Testing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
Cytogenetic
Biochemical
Molecular Testing
Hereditary Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Hereditary Testing Market Insights
- 4.1. Hereditary Testing Market – Industry Snapshot
- 4.2. Hereditary Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increase in the frequency of hereditary disorders, increased public awareness of the negative consequences, advancements in genetic analysis are the major drivers of this market
- 4.2.1.2. Growing reproduction genetic health arena
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of hereditary testing
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Hereditary Testing Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Hereditary Testing Market, by Disease Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hereditary Testing, by Disease Type, 2019-2032 (USD Billion)
- 5.3. Hereditary Cancer Testing
- 5.3.1. Global Hereditary Testing Market, by Hereditary Cancer Testing, by Region, 2019-2032 (USD Billion)
- 5.4. Lung Cancer
- 5.4.1. Global Hereditary Testing Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
- 5.5. Breast Cancer
- 5.5.1. Global Hereditary Testing Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 5.6. Colorectal Cancer
- 5.6.1. Global Hereditary Testing Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
- 5.7. Cervical Cancer
- 5.7.1. Global Hereditary Testing Market, by Cervical Cancer, by Region, 2019-2032 (USD Billion)
- 5.8. Ovarian Cancer
- 5.8.1. Global Hereditary Testing Market, by Ovarian Cancer, by Region, 2019-2032 (USD Billion)
- 5.9. Prostate Cancer
- 5.9.1. Global Hereditary Testing Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
- 5.10. Stomach/Gastric Cancer
- 5.10.1. Global Hereditary Testing Market, by Stomach/Gastric Cancer, by Region, 2019-2032 (USD Billion)
- 5.11. Melanoma
- 5.11.1. Global Hereditary Testing Market, by Melanoma, by Region, 2019-2032 (USD Billion)
- 5.12. Sarcoma
- 5.12.1. Global Hereditary Testing Market, by Sarcoma, by Region, 2019-2032 (USD Billion)
- 5.13. Uterine Cancer
- 5.13.1. Global Hereditary Testing Market, by Uterine Cancer, by Region, 2019-2032 (USD Billion)
- 5.14. Pancreatic Cancer
- 5.14.1. Global Hereditary Testing Market, by Pancreatic Cancer, by Region, 2019-2032 (USD Billion)
- 5.15. Others
- 5.15.1. Global Hereditary Testing Market, by Others, by Region, 2019-2032 (USD Billion)
- 5.16. Hereditary Non-Cancer Testing
- 5.16.1. Global Hereditary Testing Market, by Hereditary Non-Cancer Testing, by Region, 2019-2032 (USD Billion)
- 5.17. Genetic Tests
- 5.17.1. Global Hereditary Testing Market, by Genetic Tests Testing, by Region, 2019-2032 (USD Billion)
- 5.18. Cardiac Diseases
- 5.18.1. Global Hereditary Testing Market, by Cardiac Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.19. Rare Diseases
- 5.19.1. Global Hereditary Testing Market, by Rare Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.20. Other Diseases
- 5.20.1. Global Hereditary Testing Market, by Other Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.21. Newborn Genetic Screening
- 5.21.1. Global Hereditary Testing Market, by Newborn Genetic Screening Testing, by Region, 2019-2032 (USD Billion)
- 5.22. Preimplantation Genetic Diagnosis & Screening
- 5.22.1. Global Hereditary Testing Market, by Preimplantation Genetic Diagnosis & Screening Testing, by Region, 2019-2032 (USD Billion)
- 5.23. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
- 5.23.1. Global Hereditary Testing Market, by Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests Testing, by Region, 2019-2032 (USD Billion)
- 6. Global Hereditary Testing Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Cytogenetic
- 6.3.1. Global Hereditary Testing Market, by Cytogenetic, by Region, 2019-2032 (USD Billion)
- 6.4. Biochemical
- 6.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2019-2032 (USD Billion)
- 6.5. Molecular Testing
- 6.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2019-2032 (USD Billion)
- 7. Global Hereditary Testing Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Hereditary Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Hereditary Testing Market – North America
- 7.3.1. North America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.2. North America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.3.3. Hereditary Testing Market – U.S.
- 7.3.3.1. U.S.: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.3.4. Hereditary Testing Market – Canada
- 7.3.4.1. Canada: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4. Hereditary Testing Market – Europe
- 7.4.1. Europe: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.2. Europe: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.3. Hereditary Testing Market – UK
- 7.4.3.1. UK: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.4. Hereditary Testing Market – France
- 7.4.4.1. France: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.4.2. France: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.5. Hereditary Testing Market – Germany
- 7.4.5.1. Germany: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.6. Hereditary Testing Market – Italy
- 7.4.6.1. Italy: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.7. Hereditary Testing Market – Spain
- 7.4.7.1. Spain: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.8. Hereditary Testing Market – Netherlands
- 7.4.8.1. Netherlands: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.9. Hereditary Testing Market – Russia
- 7.4.9.1. Russia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5. Hereditary Testing Market – Asia Pacific
- 7.5.1. Asia Pacific: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.3. Hereditary Testing Market – China
- 7.5.3.1. China: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.3.2. China: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.4. Hereditary Testing Market – India
- 7.5.4.1. India: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.4.2. India: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.5. Hereditary Testing Market – Malaysia
- 7.5.5.1. Malaysia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.6. Hereditary Testing Market – Japan
- 7.5.6.1. Japan: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.7. Hereditary Testing Market – Indonesia
- 7.5.7.1. Indonesia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.8. Hereditary Testing Market – South Korea
- 7.5.8.1. South Korea: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6. Hereditary Testing Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.3. Hereditary Testing Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.4. Hereditary Testing Market – UAE
- 7.6.4.1. UAE: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.5. Hereditary Testing Market – Israel
- 7.6.5.1. Israel: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.6. Hereditary Testing Market – South Africa
- 7.6.6.1. South Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7. Hereditary Testing Market – Latin America
- 7.7.1. Latin America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.3. Hereditary Testing Market – Mexico
- 7.7.3.1. Mexico: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.4. Hereditary Testing Market – Brazil
- 7.7.4.1. Brazil: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.5. Hereditary Testing Market – Argentina
- 7.7.5.1. Argentina: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. include AL-KO KOBER GROUP
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Andreas Stihl AG & Company KG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Ariens Company
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Briggs & Stratton
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. CHEVRON (China) Trading Co.Ltd
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Deere & Company
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Emak S.p.A
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Excel Industries
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Inc., HONDA
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Husqvarna
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Makita Corp
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. MTD Holdings Inc
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Robert Bosch
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Schiller Ground Care
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Stanley Black & Decker
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. STIHL Group
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
- 9.17. Techtronic Industries
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
- 9.18. The Toro Company (US)
- 9.18.1. Company Overview
- 9.18.2. Financial Performance
- 9.18.3. Product Benchmarking
- 9.18.4. Recent Development
- 9.19. Yamabiko Corp
- 9.19.1. Company Overview
- 9.19.2. Financial Performance
- 9.19.3. Product Benchmarking
- 9.19.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
